Mathias L.
- Country
- Germany
- Department
- II. Medizinische Klinik
Research Overview
- Phase 2 Study on Epcoritamab Monotherapy or Combined with Lenalidomide for Anthracycline-Ineligible Diffuse Large B-Cell Lymphoma Patients
- Pilot-trial of methotrexate, tafasitamab (Minjuvi®), lenalidomide (Revlimid®) and rituximab in patients ineligible for HCT-ASCT with primary central nervous system lymphoma (PCNSL) -MTR²
- Phase I/II Study of CXCR4-Directed Theranostics Using [90Y]Y-PentixaTher and [68Ga]Ga-PentixaFor in Advanced Non-Hodgkin Lymphomas
Data & Insights
Has run more than one trial at 17 of 81 partner sites.
Specializations
Lymphoma Research
This investigator specializes in the treatment of advanced lymphoproliferative disorders, with particular emphasis on diffuse large B-cell lymphoma and its variants. Their research encompasses innovative therapeutic approaches for both systemic and central nervous system lymphomas.
- Primary CNS Lymphoma
- Non-Hodgkin Lymphomas
- B-cell Lymphoma Variants
The investigator's work includes evaluation of novel therapeutic combinations and treatment strategies for elderly patients with lymphoid malignancies.
Advanced Therapeutics
Their expertise extends to cutting-edge treatment modalities including autologous stem cell transplantation and high-dose chemotherapy protocols. The investigator explores innovative approaches in targeted therapies and immunological treatments.
- Stem Cell Transplantation
- Chemokine Receptor-Directed Therapy
- Novel Therapeutic Combinations
A particular focus lies on developing age-adjusted treatment protocols and evaluating targeted therapeutic approaches.
Clinical Innovation
The investigator develops theranostic approaches in advanced cancers, incorporating both diagnostic and therapeutic components. Their work includes evaluation of radiopeptide-based imaging and therapy techniques.
- Treatment Response Assessment
- Therapeutic Efficacy Evaluation
- Clinical Safety Protocols
Their research encompasses comprehensive assessment of treatment outcomes and therapeutic safety profiles.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.